Frequently Asked Questions
The Ischemic Heart Disease Market size will be worth USD 5,745.63 million by 2028.
The Ischemic Heart Disease Market growth rate will be 4.67% by 2028.
The high prevalence of chronic conditions such as diabetes, hypertension and cholesterol levels increasing the risk of suffering from cardiovascular diseases and rise in mortality rate are the growth drivers of the Ischemic Heart Disease Market
The disease and drug class are the factors on which the Ischemic Heart Disease Market research is based.
The major companies in the Ischemic Heart Disease Market are Amgen Inc., AstraZeneca, Bayer AG, Novartis AG, Gilead Sciences, Inc, GlaxoSmithKline plc., Pfizer Inc., Teva Pharmaceutical Industries Ltd, Cardurion Pharmaceuticals, Cardior Pharmaceuticals, Actelion Pharmaceuticals Ltd, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, CYTOKINETICS, INC., Eli Lilly and Company, Merck Sharp & Dohme Corp., Quantum Genomics, RENOVA, SERVIER LABORATORIES, Stealth BioTherapeutics Inc., Sanofi, Mylan N.V., Bausch Health Companies Inc.
